Company / Capital Expenditures
Kodiak Sciences Inc. Capital Expenditures History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$375.0K
FY2024
5-year range
$375.0K / $41.4M
FY2020-FY2024
Trend
-99.1%
vs FY2023
Sector context
#142 of 192
Health Care
What the data says
At $375,000, Kodiak Sciences Inc.'s capital expenditures ranks #142 of 192 in the Health Care sector. Declined from $37M to $375,000 over the past 2 years.
Based on SEC 10-K filings.
$375,000 in FY2024 with a 5-year CAGR of -3.0%.
Declined from $37M to $375,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -72.0%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Sector benchmark
#142 of 192 in Health CareTop 74% of 192This company $375.0K Sector average $118.6M
▼
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.0%, indicating a declining trend.
- In FY2024, capital expenditures decreased 99.1% year-over-year.
- Ranks #142 out of 192 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $375.0K | -99.1% |
| FY2023 | $41.4M | +11.7% |
| FY2022 | $37.0M | +117.4% |
| FY2021 | $17.0M | +346.6% |
| FY2020 | $3.8M | +772.8% |
| FY2019 | $437.0K | +460.3% |
| FY2018 | $78.0K | -62.7% |
| FY2017 | $209.0K | -72.9% |
| FY2016 | $771.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026